Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sulfonylurea (substance) |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Product containing metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Product containing biguanide (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Product containing troglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Product containing thiazolidinedione (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Oral hypoglycaemic identification |
Component |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Poisoning by metformin |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
forgiftning med oralt hypoglykæmikum |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Accidental poisoning by metformin |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Intentional poisoning caused by metformin (disorder) |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
forgiftning med metformin, uvist med hvilken hensigt |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Accidental phenformin poisoning |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Intentional phenformin poisoning |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
forgiftning med phenformin, uvist med hvilken hensigt |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
allergi over for hypoglykæmikum til oral anvendelse |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Allergy to biguanide (finding) |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Allergy to metformin (finding) |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Allergy to acarbose |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Oral hypoglycemic overdose |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Biguanide overdose |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Overdose of metformin |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Accidental overdose by metformin |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Intentional overdose by metformin |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
overdosis af metformin, uvist med hvilken hensigt |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
metforminhydrochloridprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Metformin hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Metformin hydrochloride 850 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Troglitazone 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Troglitazone 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Troglitazone 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Product containing rosiglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Product containing precisely rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Product containing pioglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
blodsukkersænkende middel til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
forgiftning med oralt biguanidderivat |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Rosiglitazone maleate 2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Metformin hydrochloride 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
metforminhydrochlorid 500 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
rosiglitazonmaleat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Guar gum (substance) |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Poisoning by phenformin |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Biguanide (substance) |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
blodsukkersænkende kombinationspræparat til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
pioglitazonhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Alfa-glucosid-hæmmer |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Biguanide oral hypoglycemic agent (substance) |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Product containing biguanide (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
bivirkning af blodsukkersænkende præparat til oral anvendelse |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Biguanide overdose |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
forgiftning med oralt biguanidderivat |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Adverse reaction to insulins and antidiabetic agents NOS |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
rosiglitazon 2 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Sitagliptin (substance) |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Miglitol (substance) |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Acarbose (substance) |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Vildagliptin (substance) |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
forgiftning med oralt sulfonylureaderivat |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
allergi over for hypoglykæmikum til oral anvendelse |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
1 |
Linagliptin (substance) |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Alogliptin |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Saxagliptin (substance) |
Is a |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|
Allergy to guar gum (finding) |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
2 |
Guar gum adverse reaction |
Causative agent |
False |
Oralt blodsukkersænkende middel |
Inferred relationship |
Some |
|